HopeStage
Back to all studies
CompletedNCT00382291

Sertraline dose schedules with cognitive behavioral therapy for OCD

About this title

Effectiveness of Sertraline and Cognitive Behavioral Therapy in Treating Pediatric Obsessive-Compulsive Disorder

Read the official source — NCT00382291
Medication studyAges 7–17United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 7 years to 17 years.

Listed locations
Gainesville and 1 more locationSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateFebruary 2009
Recruitment status
Completed
Enrollment listed in the registry
56
Sponsor
University of Florida
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 7 Years to 17 Years
Official registry ID
NCT00382291
Official title
Show the full official title

SSRI-Induced Activation Syndrome in Pediatric Obsessive Compulsive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Gainesville · Tampa

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Florida, a university.

Did this study involve medication?

Yes. The study involved medication, including Regular Titration, Placebo and Slow Titration.

Who was this study for?

Listed age limits: 7 years to 17 years.

Want to explore more studies?

Explore studies